84results about How to "High treatment rate" patented technology

The invention relates to bio-electrochemical systems for treating wastewater, and sour gas produced by anaerobic digestion of organic material. The invention further relates to novel anode / cathode pairing schemes, and electric and hydraulic architectures for use in bio-electrochemical systems.

Provided is a porous multilayer filter which can trap ultrafme particles and in which permeability is high and treatment can be performed at a high flow rate. A porous multilayer filter is characterized by including a support layer 2 composed of a porous expanded PTFE sheet, and a filtration layer 3 composed of a porous expanded PTFE sheet which is different from that of the support layer 2, wherein at least a liquid-to-be-treated inflow surface of the filtration layer 3 is subjected to hydrophilization treatment, the filtration layer 3 and the support layer 2 are fusion-bonded to each other at a boundary therebetween to form a multilayer structure, pores of the support layer 2 three-dimensionally communicate with pores of the filtration layer 3, and pores surrounded by a fibril skeleton of the filtration layer 3 are smaller than pores of the support layer 2.

Embodiments of the invention provide shaped masses comprising one or more drugs such as proteins or polypeptides and methods for forming such shaped masses. One embodiment provides a shaped mass comprising a drug such as a protein or polypeptide having a biological activity in the body of a mammal. The shaped mass is formed by compression of a precursor material comprising the drug wherein an amount of biologically active drug in the mass is a preserved above a minimum level. Drugs which may be incorporated into the shaped mass may include one or more glucose regulating proteins such as insulin, incretins; and immunoglobulins such as TNF-inhibiting antibodies or interleukin neutralizing antibodies. Embodiments of the shaped mass may be incorporated into a tissue penetrating member which is inserted into the intestinal wall allowing for the oral delivery of proteins and peptides which would otherwise be degraded in the intestinal tract.

Embodiments of the invention provide shaped masses comprising one or more drugs such as proteins or polypeptides and methods for forming such shaped masses. One embodiment provides a shaped mass comprising a drug such as a protein or polypeptide having a biological activity in the body of a mammal. The shaped mass is formed by compression of a precursor material comprising the drug wherein an amount of biologically active drug in the mass is a preserved above a minimum level. Drugs which may be incorporated into the shaped mass may include one or more glucose regulating proteins such as insulin, incretins; and immunoglobulins such as TNF-inhibiting antibodies or interleukin neutralizing antibodies. Embodiments of the shaped mass may be incorporated into a tissue penetrating member which is inserted into the intestinal wall allowing for the oral delivery of proteins and peptides which would otherwise be degraded in the intestinal tract.

Embodiments of the invention provide shaped masses comprising one or more drugs such as proteins or polypeptides and methods for forming such shaped masses. One embodiment provides a shaped mass comprising a drug such as a protein or polypeptide having a biological activity in the body of a mammal. The shaped mass is formed by compression of a precursor material comprising the drug wherein an amount of biologically active drug in the mass is a preserved above a minimum level. Drugs which may be incorporated into the shaped mass may include one or more glucose regulating proteins such as insulin, incretins; and immunoglobulins such as TNF-inhibiting antibodies or interleukin neutralizing antibodies. Embodiments of the shaped mass may be incorporated into a tissue penetrating member which is inserted into the intestinal wall allowing for the oral delivery of proteins and peptides which would otherwise be degraded in the intestinal tract.

The present invention relates to a method and apparatus for treating materials such as copper or copper based metal alloys, used in fabricating semiconductor devices with an ozone solvent solution and avoiding damage to metals by corrosion. The invention is also applicable to treating of materials such as copper and copper based alloys for the purpose of forming a protective layer on the exposed metal surface for protection of those copper surfaces from damage or corrosion caused by subsequent exposure to other liquid, gas, or plasma environments. This can be achieved by properly selecting the composition of the ozone solvent solution and controlling the pH and ORP of the ozone-solvent solution while avoiding the use of certain chemical constituents in the ozone solvent solution.

A substrate treating method is disclosed, in which a treating solution containing phosphoric acid is heated for use in treating a substrate coated with a film including a material of high dielectric constant.

The present invention provides antibody polypeptides with binding specificity for human kallikrein-2 (hK2), wherein the antibody polypeptide comprises (a) a heavy chain variable region comprising the amino acid sequences of SEQ ID NO: 1 and SEQ ID NO: 2 and SEQ ID NO: 3 and / or (b) a light chain variable region comprising the amino acid sequences of SEQ ID NO: 4 and SEQ ID NO: 5 and SEQ ID NO: 6, and wherein the heavy chain variable region and light chain variable region comprise framework amino acid sequences from one or more human antibodies. The invention further provides use of said antibody polypeptides in the diagnosis and treatment of prostate cancer.

The present invention is directed to a method for reducing the emetogenic effects of PDE inhibitors, and more particularly is directed to compounds having PDE4 inhibition activity with little or no emetogenic side-effects, and chemical methods including benzylation for preparing such compounds. A benzyl group may be attached to either a carbon or nitrogen atom of a PDE4 inhibitor. Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, and then react the resulting nucleophilic PDE4 inhibitor with a benzylating agent, e.g., benzyl bromide or a derivative thereof.

The present invention provides bio-electrochemical systems having various configurations for the treatment of water, wastewater, gases, and other biodegradable matter. In one aspect, the invention provides bio-electrochemical systems configured for treating wastewater while generating multiple outputs. In another aspect, the invention provides bio-electrochemical systems configured for improving the efficiency of electrodialysis removal systems. In yet another aspect, the invention provides bio-electrochemical systems configured for use in banks and basins.

A method for removing contaminant from feedwater by forming a dispersion comprising bubbles of a treatment gas in a continuous phase comprising feedwater, wherein the bubbles have a mean diameter of less than about 5 μm and wherein the treatment gas is selected from air, oxygen, and chlorine. A method for removing contaminants from a feedwater by subjecting a fluid mixture comprising feedwater and a treatment gas to a shear rate greater than 20,000 s−1 in a high shear device to produce a dispersion of treatment gas in a continuous phase of the feedwater. A system for treating feedwater to remove contaminants therefrom is also presented, the system comprising at least one high shear mixing device comprising at least one generator comprising a rotor and a stator separated by a shear gap; and a pump configured for delivering feedwater and treatment gas to the high shear mixing device.

A method for treating a polymetallic sulfide ore containing gold and / or silver, and further containing base metals selected from the group consisting of iron, aluminum, chromium, titanium, copper, zinc, lead, nickel, cobalt, mercury, tin, and mixtures thereof, is disclosed. The method comprises the steps of grinding the polymetallic sulfide ore to produce granules, oxidizing the granules to produce oxidized granules, and chloride leaching the granules using a brine solution including dissolved halogens, as well as chloride and bromide salts.

The present disclosure demonstrates the successful use of constitutive promoters operatively linked to genes encoding radiosensitizing or radioprotecting factors, administered to cells, tissues, or patients in conjunction with radiation exposure. Also disclosed are pharmacological preparations to be used to increase the levels of radiosensitizing compounds such as TNF-α, or radioprotective compounds such as MnSOD, in specified tissues or tumors of a subject.

Disclosed herein is a method of manufacturing a laminate for a flexible printed circuit board, in which a base film is surface treated by radiating ion beams using a gas mixture comprising oxygen and argon. According to the method of the current invention, a laminate for a flexible printed circuit board, having high adhesive strength, heat resistance, dimensional stability, and productivity, can be manufactured.

In a filter for microfiltration, a filtration layer is protected so as not to be damaged. A porous multi-layer filter, which is a laminated body of three porous stretched PTFE sheets that have been biaxially stretched in the longitudinal and transverse directions, includes a filtration layer as a middle layer, a protection layer stacked on one surface of the filtration layer on the liquid-to-be-treated inflow side, and a support layer stacked on another surface of the filtration layer, in which the one surface and the other surface of the filtration layer are fusion-bonded to the protection layer and the support layer at boundaries therebetween, pores of the protection layer and pores of the support layer three-dimensionally communicate with pores of the filtration layer, and the mean pore size of pores of the filtration layer is smaller than the mean pore size of pores of each of the protection layer and the support layer.

Embodiments of the invention provide shaped masses comprising one or more drugs such as proteins or polypeptides and methods for forming such shaped masses. One embodiment provides a shaped mass comprising a drug such as a protein or polypeptide having a biological activity in the body of a mammal. The shaped mass is formed by compression of a precursor material comprising the drug wherein an amount of biologically active drug in the mass is a preserved above a minimum level. Drugs which may be incorporated into the shaped mass may include one or more glucose regulating proteins such as insulin, incretins; and immunoglobulins such as TNF-inhibiting antibodies or interleukin neutralizing antibodies. Embodiments of the shaped mass may be incorporated into a tissue penetrating member which is inserted into the intestinal wall allowing for the oral delivery of proteins and peptides which would otherwise be degraded in the intestinal tract.

A system for treating feedwater to remove contaminants therefrom, the system comprising at least one high shear mixing device comprising at least one generator comprising a rotor and a stator separated by a shear gap, wherein the shear gap is the minimum distance between the rotor and the stator, and wherein the high shear mixing device is capable of producing a tip speed of the rotor of greater than 22.9 m / s (4,500 ft / min) and a pump configured for delivering feedwater and treatment gas selected from oxygen, air, and chlorine to the high shear mixing device.

A gas treatment apparatus for treating gas with non-thermal plasma includes dielectric elements disposed in a space between electrodes. The dielectric elements each include a ferroelectric core covered with adsorbent that supports a metal catalyst or that is mixed with a metal catalyst.

The present application provides an agent comprising or consisting of a binding moiety with specificity for a kallikrein protein (for example, PSA or hK2) for use in the treatment of prostate cancer, and a method for the treatment of prostate cancer in a patient, the method comprising the step of administering a therapeutically effective amount of an agent comprising or consisting of a binding moiety with specificity for a kallikrein protein to the patient.

The invention discloses external ointment for treating infantile eczema and belongs to the technical field of traditional Chinese medicine. The external ointment comprises cortex dictamni, fructus arctii, rhizoma coptidis, tetrapanax papyriferus, poria cocos, fructus amomi, medicated leaven, liquorice, herba violae, rhizoma belamcandae, radix sophorae tonkinensis, hedyotis diffusa, brucea javanica, radix lithospermi, red peony root, moutan bark, sanguisorba officinalis, pagoda tree pod, semen plantaginis, fructus kochiae, desmodium, lygodium japonicum, pyrrosia lingua, polygonum cuspidatum, caulis aristolochiae manshuriensis, diploclisia affinis, smallfruit fig aerial root, puffball and vaseline. The external ointment has the advantages that the various traditional Chinese medicine materials of the external ointment are scientifically combined to achieve a synergic effect, the external ointment has effects of clearing away heat and toxic materials, cooling blood and excreting dampness and tonifying qi and benefiting middle-jiao, and the external ointment is short in treatment course, fast to become effective, high in cure rate and worthy of popularization.

The invention discloses medicinal liquor for curing nephropathy and a preparation method thereof. The medicinal liquor is prepared from the following Chinese medicinal plants in parts by weight: 20-30 parts of cordyceps sinensis, 30-40 parts of radix astragali, 30-40 parts of tuckahoe, 30-40 parts of motherwort, 20-30 parts of rhizoma zingiberis, 30-40 parts of houttuynia cordata, 10-20 parts of ephedra, 20-30 parts of pericarpium arecae, 30-40 parts of golden cypress, 30-40 parts of Chinese pyrola herb, 20-30 parts of cassia twig and 30-40 parts of mongolian dandelion herb. The preparation method is as follows: 1) preprocessing the Chinese medicinal plants: sorting, cleaning, cutting, drying, grinding, sterilizing, drying and sieving the Chinese medicinal plants; 2) weighting the raw materials processed in step 1), and soaking in yellow wine for 1 hour, wherein the ratio of the total raw material weight to the wine yellow weight is (1-3):(7-9); and 3) steaming the raw materials along with the yellow wine for 2-3 hours in a pot, cooling, and filtering out the yellow wine to obtain the medicinal liquor. Clinical applications prove that the medicinal liquor is safe, and has no toxic or side effect, high total effective rate, and high recovery rate (up to about 90%) for nephropathy.

The present invention provides antibody polypeptides with binding specificity for human kallikrein-2 (hK2), wherein the antibody polypeptide comprises (a) a heavy chain variable region comprising the amino acid sequences of SEQ ID NO: 1 and SEQ ID NO: 2 and SEQ ID NO: 3 and / or (b) a light chain variable region comprising the amino acid sequences of SEQ ID NO: 4 and SEQ ID NO: 5 and SEQ ID NO: 6, and wherein the heavy chain variable region and light chain variable region comprise framework amino acid sequences from one or more human antibodies. The invention further provides use of said antibody polypeptides in the diagnosis and treatment of prostate cancer.

[Problems] To provide a method of treating an organic substance-containing waste liquid, and a treatment apparatus therefor, and an additive for treating an organic substance-containing waste liquid, and a bacterium for degrading an organic substance component or the like in the waste liquid, capable of accomplishing at least one of treatment of the organic substance-containing waste liquid with a high efficiency and a high treatment rate, without substantially generating a foul odor, and obtainment of water quality that is suitable for releasing to sewage, a public water area, or the like.[Solving Means] A method of treating an organic substance-containing waste liquid, and a treatment apparatus therefor each characterized by contacting an activated sludge containing a specified bacterium and an organic substance-containing waste liquid; and an additive for treating an organic substance-containing waste liquid, comprising adding the additive to an activated sludge in a treatment tank in which a specified bacterium is present, and a specified bacterium for degrading an organic substance-containing waste liquid.

The invention provides a transfer factor and application thereof. The transfer factor is prepared by using a frozen-breaking process and a high-pressure breaking process in a combined manner, so that production temperature is lowered, and activity of the transfer factor can be maintained more efficiently; due to the fact that a freezing-thawing step is not needed, production period of semifinished products is shortened to be one day and shortened greatly when compared with that of conventional freezing-thawing methods and dialysis methods. In addition, transfer factor yield of the increased remarkably. Healthy pig spleen is taken as a raw material, a transfer factor solution is prepared through fat removing, cell breaking, microfiltration and ultrafiltration, the transfer factor does not contain protein, belongs to micromolecule polypeptide, is free of pyrogen and toxic reaction and is a widely-applied immunomodulator, and activity of the transfer factor cannot be damaged by pancreatin. The transfer factor can play a remarkable role in promoting immunity of livestock and poultry and is conducive to improving vaccine titer, prolonging antibody duration, enhancing an organism immune function and increasing treatment rate.

The object of the present invention is to solve problems of treatment time when using an SLS method or continuous-oscillation laser. An indispensable portion is scanned with a laser beam in order to crystallize a semiconductor film by driving a laser and so on in accordance with the positions of islands instead of scanning and irradiating the whole semiconductor film. The present invention makes it possible to omit the time for irradiating a portion to be removed through patterning after crystallizing the semiconductor film with a laser beam and greatly shorten the treatment time for one substrate.